"Unsurprisingly, frustrations are routinely directed at the strata manager simply because they perform the administrative ...

As of Friday, January 23, Nektar Therapeutics’s NKTR share price has surged by 7.36%, which has investors questioning if this ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

The S&P/TSX Composite Index ended up 142.28 points, or 0.4%, at 33,144.98, eclipsing Monday's record closing high. For the week, the index was up 0.3%, despite a sharp drop on Tuesday that was tied to ...

Bausch Health Companies Inc. was hit by a failed RED-C Phase 3, weak cash flow vs. interest, and a risky pipeline. Click for ...

In midday trading, the Toronto Stock Exchange's S&P/TSX Composite Index was 0.3% higher at 33103.31. That puts the index in line for a gain of slightly less than 0.2% this week, adding to gains so far ...

The Dow Jones Industrial Average (DJI) is sinking over 200 points as Goldman Sachs (GS) and Intel (INTC) weigh heavy ...

Jan 23 (Reuters) - Bausch Health said on Friday its experimental treatment failed to prevent the first clinically visible ...

Check out the companies making headlines in midday trading. Fortinet — Shares jumped more than 7% after TD Cowen upgraded the cybersecurity stock to buy from hold, saying rising memory prices won't ...

A potential inflection point that Bausch Health hoped could diversify its portfolio has vanished with a pair of phase 3 failures for a new formulation of the company’s bread-and-butter Xifaxan—a ...

Shares of Bausch Health (NYSE:BHC) dropped about 8% in early trading on Friday after the company disclosed unsuccessful ...